HK$
0.21
Jan 8
Business Description
Innovative Pharmaceutical Biotech Ltd
ISIN : BMG4783W1073
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.33 | |||||
Debt-to-Equity | -1.85 | |||||
Debt-to-EBITDA | 4.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.79 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.1 | |||||
3-Year FCF Growth Rate | 43.9 | |||||
3-Year Book Growth Rate | 4.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.96 | |||||
9-Day RSI | 62.96 | |||||
14-Day RSI | 58.98 | |||||
6-1 Month Momentum % | -16.96 | |||||
12-1 Month Momentum % | -9.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Days Sales Outstanding | 286.24 | |||||
Days Payable | 184.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | 43.55 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 13.01 | |||||
Operating Margin % | -242.7 | |||||
Net Margin % | 194.33 | |||||
FCF Margin % | -110.79 | |||||
ROE % | Neg. Equity | |||||
ROA % | 0.83 | |||||
ROIC % | -0.77 | |||||
ROC (Joel Greenblatt) % | 37193.09 | |||||
ROCE % | 24.97 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 103.5 | |||||
EV-to-EBIT | 10.32 | |||||
EV-to-EBITDA | 10.32 | |||||
EV-to-Revenue | 367.68 | |||||
EV-to-FCF | -331.87 | |||||
Earnings Yield (Greenblatt) % | 9.69 | |||||
FCF Yield % | -1.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Innovative Pharmaceutical Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 5.895 | ||
EPS (TTM) (HK$) | -0.067 | ||
Beta | 0.1 | ||
Volatility % | 23.44 | ||
14-Day RSI | 58.98 | ||
14-Day ATR (HK$) | 0.01045 | ||
20-Day SMA (HK$) | 0.1968 | ||
12-1 Month Momentum % | -9.05 | ||
52-Week Range (HK$) | 0.179 - 0.29 | ||
Shares Outstanding (Mil) | 1,822.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Innovative Pharmaceutical Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Innovative Pharmaceutical Biotech Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Innovative Pharmaceutical Biotech Ltd Frequently Asked Questions
What is Innovative Pharmaceutical Biotech Ltd(HKSE:00399)'s stock price today?
When is next earnings date of Innovative Pharmaceutical Biotech Ltd(HKSE:00399)?
Does Innovative Pharmaceutical Biotech Ltd(HKSE:00399) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |